(S)-1-(3-(2-(2,6-difluorophenyl)imidazo[1,5-b]pyridazin-7-ylamino)pyridin-4-yl)piperidin-3-ol

ID: ALA3920197

Chembl Id: CHEMBL3920197

PubChem CID: 71007225

Max Phase: Preclinical

Molecular Formula: C22H20F2N6O

Molecular Weight: 422.44

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  O[C@H]1CCCN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1

Standard InChI:  InChI=1S/C22H20F2N6O/c23-16-4-1-5-17(24)21(16)18-7-6-14-11-26-22(30(14)28-18)27-19-12-25-9-8-20(19)29-10-2-3-15(31)13-29/h1,4-9,11-12,15,31H,2-3,10,13H2,(H,26,27)/t15-/m0/s1

Standard InChI Key:  VCGNDPLDVLHZGK-HNNXBMFYSA-N

Alternative Forms

1. Parent:

   

   ALA3920197

   (3S)-1-[3-[[2-(2,6-difluorophenyl)imidazo[1,5-b]pyridazin-7-yl]amino]pyridin-4-yl]piperidin-3-ol

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 422.44

Molecular Weight (Monoisotopic): 422.1667

AlogP: 3.77

#Rotatable Bonds: 4

Polar Surface Area: 78.58

Molecular Species: BASE

HBA: 7

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 8.73

CX LogP: 3.41

CX LogD: 2.57

Aromatic Rings: 4

Heavy Atoms: 31

QED Weighted: 0.52

Np Likeness Score: -1.30

References

1. Wurz RP, Sastri C, D'Amico DC, Herberich B, Jackson CLM, Pettus LH, Tasker AS, Wu B, Guerrero N, Lipford JR, Winston JT, Yang Y, Wang P, Nguyen Y, Andrews KL, Huang X, Lee MR, Mohr C, Zhang JD, Reid DL, Xu Y, Zhou Y, Wang HL..  (2016)  Discovery of imidazopyridazines as potent Pim-1/2 kinase inhibitors.,  26  (22): [PMID:27769621] [10.1016/j.bmcl.2016.09.067]

2.  (2015)  Bicyclic pyridazine compounds as Pim inhibitors, 

Source

Source(2):

• Scientific Literature
• BindingDB Database